Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR6890 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C12orf45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C12orf57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01424 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SENP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXLD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBFA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V0A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFYB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNRNP25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG101 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP128 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAD2L1BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on